Weimob (2013.HK HKSE) trades HK$2.18 on 05 Feb 2026: watch intraday volume

The most active stock on our Hong Kong screen, Weimob Inc. (2013.HK) is trading at HK$2.18 mid-session on 05 Feb 2026 after a high of HK$2.32 intraday. 2013.HK stock shows unusually large turnover of 185,357,149 shares versus an average of 83,024,470. This spike in liquidity is driving short-term price moves as traders react to weak earnings history, high leverage and a volatile tech sector backdrop. Watch volume to confirm follow-through for a move above HK$2.32 or a pullback toward HK$2.11.

Intraday movers: 2013.HK stock volume surge

Weimob (2013.HK) is the session leader by volume with 185,357,149 shares traded and a relative volume of 2.26, which signals heavy intraday interest.

This single fact explains much of the price action; traders are testing liquidity between the day low HK$2.11 and day high HK$2.32, with the open at HK$2.30 and previous close HK$2.18.

Fundamentals and valuation for Weimob (2013.HK)

Weimob’s trailing EPS is -0.44 and reported PE is -4.55, reflecting negative earnings and a turnaround narrative.

The balance sheet and ratios show pressure: price-to-book 3.03, debt-to-equity 1.22, and current ratio 0.97, which compare unfavourably with Hong Kong tech peers that have an average current ratio near 2.90.

Technical snapshot and intraday levels

Momentum indicators are mixed: RSI 58.24, MACD histogram 0.03, and ADX 33.38 indicating a strong intraday trend.

Key levels to watch today are resistance HK$2.32 and support HK$2.11, with 50-day average at HK$2.07 and 200-day average at HK$2.12 guiding short-term bias.

Meyka grade and forecast for 2013.HK stock

Meyka AI rates 2013.HK with a score out of 100: 63.78 | Grade: B | Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus.

Meyka AI’s forecast model projects a 12-month price of HK$2.97, a monthly target of HK$3.21 and a quarterly estimate of HK$1.88; the 12-month projection implies an upside of 36.33% from the current HK$2.18. Forecasts are model-based projections and not guarantees.

Risks and catalysts for Weimob (2013.HK)

Near-term risks include continued negative EPS, tight liquidity metrics, rising operating costs and dependence on Chinese SME advertising budgets.

Potential catalysts are improved subscription revenue growth, margin recovery from product mix, and any positive update ahead of the next earnings announcement on 26 Mar 2026.

Trading context, sector comparison and price targets

On a sector basis, Technology peers show higher average PE (35.85) and stronger current ratios, highlighting valuation and balance-sheet divergence for Weimob.

For active traders we set intraday targets: conservative resistance HK$2.32, higher intraday pivot HK$2.50, and a model-based 12-month price target HK$2.97; use strict stops near HK$2.05 and watch volume for conviction. Read full company details on the issuer site and our stock page Weimob investor site and Meyka stock page. For recent coverage see Reuters analysis source.

Final Thoughts

Weimob Inc. (2013.HK) is an intraday market leader in Hong Kong today because of exceptionally high trade volume and visible short-term momentum around HK$2.18. Fundamentals remain weak with EPS -0.44, a negative PE and a stretched current ratio 0.97, which keeps the stock in a higher-risk category compared with the wider Technology sector. Meyka AI’s model-based 12-month projection of HK$2.97 implies an upside of 36.33% from the current price, while a shorter monthly signal at HK$3.21 shows a more bullish scenario. Traders should match position size to liquidity and use intraday volume as a confirmation tool. Forecasts are model projections and not guarantees; consider this a data-backed view from an AI-powered market analysis platform and perform your own due diligence before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.